CACLP 2025 Unveils the Latest Exhibitor List and Global Collaboration and Innovation Highlights Next March

Taking place 22-24 March at the Hangzhou Grand Convention & Exhibition Center, CACLP 2025—the 22nd China International In Vitro Diagnostic Expo—will make a significant impact, bringing a sharp focus to global innovation and industry collaboration. With the theme "Innovation for a Better Future", the event is set to bring together industry leaders and emerging players. The preliminary exhibitor list features an impressive range of global participants, ready to showcase cutting-edge advancements and connect with local resources in China’s fast growing in vitro diagnostics (IVD) market.

Over 1,200 exhibitors from around the globe have already confirmed their participation. Renowned global leaders including Danaher Corporation and its 11 subsidiaries, Roche, and Abbott will return to this influential platform. Canon, a leader in imaging and photography, will make its debut at CACLP, signaling its new commitment to the IVD market. Delegations from countries across Europe, the Americas, and Asia will bring companies and expert teams seeking to expand in China’s IVD market, showcase advanced diagnostic technologies and spotlight global industry trends.

In addition to a robust exhibitor lineup, CACLP 2025 will feature an array of engaging onsite activities designed to bring together key focus areas and facilitate direct industry interactions for participants. A new in-hall presentation space, the Global Innovation and Technology Application Presentation Area, will give companies a dynamic stage to present groundbreaking products up close, allowing visitors to experience and explore new diagnostic solutions firsthand. 

The event will further strengthen international ties through the Global Investment Forum, which offers practical support and valuable insights for Chinese companies seeking to enter foreign markets. With support from embassies and trade offices worldwide, CACLP 2025 serves as a key platform for fostering cross-border collaborations. Asia-Pacific IVD associations and their expert delegations will underscore the dynamism of the region’s market and the increasing global influence. This year, CACLP introduces a dedicated Veterinary Diagnosis Zone focused on emerging trends in animal health, alongside the AI and Digital Twin Technology Salon, highlighting how these groundbreaking technologies are reshaping diagnostics. Participants will explore growth opportunities in this expanding field, which offers promising potential for the future of diagnostics.

To further enhance accessibility, China is continuously optimizing its accessible visa policies, offering mutual visa exemptions with 24 countries, visa-free entry for 16 countries, and streamlined transit options for travelers from 54 countries. These initiatives will facilitate international participation and collaboration at CACLP 2025.

CACLP 2025 is set to be a landmark event for the IVD industry, fostering global partnerships, showcasing pioneering innovations, and creating new avenues for growth. For more information or to inquire about participating, please visit en.caclp.com.

About GL events

GL events is a world-class leading provider of integrated solutions and services for events operating across the 3 major core divisions: Venues (venue management), Exhibitions (exhibition organizing) and Live (event services).

Through its wide global network made up of more than 90 offices, with organizing over 480 proprietary trade fair and events, managing more than 60 venues, and staging more than 4,200 events every year, GL events Group is a critical force for city promotion of 28 MICE destinations.

Present on five continents with operations in more than 20 countries, GL events has over 5,119 employees. Listed on the Eurolist Euronext Compartment B (Paris Stock Exchange), GL events had a turnover of €1.315bn in 2022.

About CACLP

Debut launched in 1991, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. China IVD Supply Chain Expo, successfully launched in 2021, further expands the product sectors from upstream to downstream. With a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP proves itself as one of the most important platforms for global IVD players.

In 2020, CACLP formed the joint-venture company with GL events to start the internationalism strategy.